Title:
TESTICULAR FUNCTION IMPROVING AGENT AND TESTICULAR FUNCTION IMPROVING METHOD
Document Type and Number:
WIPO Patent Application WO/2021/260986
Kind Code:
A1
Abstract:
This testicular function improving agent includes microparticles derived from a culture supernatant of dental pulp-derived stem cells, adipose-derived stem cells, or immortalized stem cells of these two, and the testicular function improvement is: an improvement in the ability of the testicles themselves to form sperm, an improvement in the function of the sperm itself obtained from the testicles, and an improvement in the function of the sperm obtained from the testicles in relation to the effect thereof on a female, as well as rejuvenating these functions when they have decayed due to old age; or sperm activation via addition to semen that has been extracted outside the body of an animal. The testicular function improving agent markedly improves the testicular function of an animal.
Inventors:
KOGA SHOJI (JP)
Application Number:
PCT/JP2021/002962
Publication Date:
December 30, 2021
Filing Date:
January 28, 2021
Export Citation:
Assignee:
DEXON PHARMACEUTICALS INC (JP)
International Classes:
A61K35/32; A61K35/28; A61P15/08
Domestic Patent References:
| WO2018038180A1 | 2018-03-01 | |||
| WO2018038180A1 | 2018-03-01 |
Foreign References:
| JP2017025038A | 2017-02-02 | |||
| JP2017119646A | 2017-07-06 | |||
| JP2015082987A | 2015-04-30 | |||
| JP2019524824A | 2019-09-05 | |||
| JP2018023343A | 2018-02-15 | |||
| JP6296622B2 | 2018-03-20 |
Other References:
"Developed a radical treatment for ED by regenerative medicine ", GINZA SOLARIA CLINIC PRESS RELEASE, 18 October 2016 (2016-10-18), XP055896038, Retrieved from the Internet [retrieved on 20220228]
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF: